This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-342-3p | AADAC | 1.22 | 0 | -4.47 | 0 | miRanda | -0.67 | 0 | NA | |
2 | hsa-miR-27a-5p | ABAT | -1.24 | 0 | 0.64 | 0.00201 | miRNATAP | -0.31 | 0 | NA | |
3 | hsa-miR-342-3p | ABCA13 | 1.22 | 0 | -1.78 | 0 | miRanda | -0.5 | 0 | NA | |
4 | hsa-miR-342-3p | ABCA6 | 1.22 | 0 | -3.37 | 0 | miRanda | -0.3 | 0 | NA | |
5 | hsa-miR-342-3p | ABCC9 | 1.22 | 0 | -2.42 | 0 | miRanda | -0.26 | 0 | NA | |
6 | hsa-miR-214-3p | ABHD2 | -0.52 | 0.00021 | 0.45 | 0.00053 | miRNATAP | -0.12 | 0.00013 | NA | |
7 | hsa-miR-24-2-5p | ACADSB | -0.22 | 0.05957 | -0.52 | 0.002 | MirTarget | -0.41 | 0 | NA | |
8 | hsa-miR-532-3p | ACBD4 | -0.4 | 0.00687 | -0.42 | 0.00049 | miRNATAP | -0.3 | 0 | NA | |
9 | hsa-miR-342-3p | ACER3 | 1.22 | 0 | -0.64 | 0 | miRanda | -0.1 | 0.00023 | NA | |
10 | hsa-miR-214-3p | ACLY | -0.52 | 0.00021 | 0.43 | 0 | MirTarget | -0.13 | 0 | NA | |
11 | hsa-miR-342-3p | ACSL4 | 1.22 | 0 | -1.48 | 0 | MirTarget; miRanda | -0.26 | 0 | NA | |
12 | hsa-miR-532-3p | ACVR1B | -0.4 | 0.00687 | 0.15 | 0.02139 | PITA; miRNATAP | -0.11 | 0 | NA | |
13 | hsa-miR-342-3p | ACVRL1 | 1.22 | 0 | -0.99 | 0 | miRanda | -0.16 | 0 | NA | |
14 | hsa-miR-342-3p | ADAM9 | 1.22 | 0 | -0.03 | 0.77501 | miRanda | -0.14 | 0 | NA | |
15 | hsa-miR-342-3p | ADAMTS1 | 1.22 | 0 | -2.52 | 0 | miRanda | -0.41 | 0 | NA | |
16 | hsa-miR-532-3p | ADAMTS13 | -0.4 | 0.00687 | 0.49 | 0.00058 | miRNATAP | -0.3 | 0 | NA | |
17 | hsa-miR-143-5p | ADAMTS8 | -1.09 | 0 | -1.48 | 0 | MirTarget | -0.14 | 0.0026 | NA | |
18 | hsa-miR-342-3p | ADARB1 | 1.22 | 0 | -0.6 | 0 | miRanda | -0.13 | 0 | NA | |
19 | hsa-miR-214-3p | ADCY1 | -0.52 | 0.00021 | -0.05 | 0.84149 | mirMAP | -0.12 | 0.03717 | NA | |
20 | hsa-miR-342-3p | ADCY2 | 1.22 | 0 | -0.73 | 0.00385 | miRanda | -0.39 | 0 | NA | |
21 | hsa-miR-342-3p | ADCY3 | 1.22 | 0 | -0.58 | 0 | miRanda | -0.14 | 0 | NA | |
22 | hsa-miR-532-3p | ADCY6 | -0.4 | 0.00687 | -0.63 | 0 | PITA | -0.17 | 0 | NA | |
23 | hsa-miR-342-3p | ADH1B | 1.22 | 0 | -7.23 | 0 | miRanda | -0.54 | 2.0E-5 | NA | |
24 | hsa-miR-342-3p | ADI1 | 1.22 | 0 | -0.35 | 3.0E-5 | miRanda | -0.14 | 0 | NA | |
25 | hsa-miR-214-3p | ADM2 | -0.52 | 0.00021 | 2.41 | 0 | mirMAP | -0.2 | 0 | NA | |
26 | hsa-miR-342-3p | ADORA2B | 1.22 | 0 | -0.76 | 0 | miRanda | -0.34 | 0 | NA | |
27 | hsa-miR-342-3p | ADRA1A | 1.22 | 0 | -4.75 | 0 | miRanda | -0.46 | 0 | NA | |
28 | hsa-miR-342-3p | ADRA2B | 1.22 | 0 | -1.36 | 0 | miRanda | -0.24 | 0 | NA | |
29 | hsa-miR-342-3p | ADRB1 | 1.22 | 0 | -2.83 | 0 | PITA; miRanda | -0.29 | 2.0E-5 | NA | |
30 | hsa-miR-342-3p | AFF2 | 1.22 | 0 | -1.78 | 0 | mirMAP | -0.32 | 0 | NA | |
31 | hsa-miR-342-3p | AGAP11 | 1.22 | 0 | -2.72 | 0 | miRanda | -0.12 | 0.00734 | NA | |
32 | hsa-miR-193a-5p | AGAP3 | -1.15 | 0 | 0.28 | 0.00021 | miRNATAP | -0.11 | 8.0E-5 | NA | |
33 | hsa-miR-214-3p | AGPAT3 | -0.52 | 0.00021 | 0.34 | 0 | mirMAP | -0.11 | 0 | NA | |
34 | hsa-miR-342-3p | AGPAT4 | 1.22 | 0 | -0.74 | 0 | MirTarget | -0.32 | 0 | NA | |
35 | hsa-miR-342-3p | AIFM2 | 1.22 | 0 | -1.44 | 0 | miRanda | -0.15 | 0 | NA | |
36 | hsa-miR-342-3p | AK5 | 1.22 | 0 | -3.09 | 0 | miRanda | -0.19 | 0.00828 | NA | |
37 | hsa-miR-342-3p | AKAP7 | 1.22 | 0 | -1.02 | 0 | miRanda | -0.13 | 0 | NA | |
38 | hsa-miR-342-3p | AKR1B1 | 1.22 | 0 | -0.51 | 0 | miRanda | -0.18 | 0 | NA | |
39 | hsa-miR-532-3p | ALCAM | -0.4 | 0.00687 | 0.51 | 0.00106 | MirTarget; PITA; miRNATAP | -0.21 | 0 | NA | |
40 | hsa-miR-342-3p | ALS2CL | 1.22 | 0 | -1.15 | 0 | mirMAP | -0.21 | 0 | NA | |
41 | hsa-miR-342-3p | ALS2CR11 | 1.22 | 0 | -1.63 | 0 | miRanda | -0.13 | 0.00564 | NA | |
42 | hsa-miR-342-3p | ALX4 | 1.22 | 0 | -3.22 | 0 | mirMAP | -0.43 | 0 | NA | |
43 | hsa-miR-532-3p | AMDHD2 | -0.4 | 0.00687 | 0.93 | 0 | mirMAP | -0.24 | 0 | NA | |
44 | hsa-miR-342-3p | AMOT | 1.22 | 0 | -0.91 | 0 | miRanda | -0.13 | 3.0E-5 | NA | |
45 | hsa-miR-342-3p | ANGPTL1 | 1.22 | 0 | -3.72 | 0 | miRanda | -0.33 | 0 | NA | |
46 | hsa-miR-342-3p | ANGPTL2 | 1.22 | 0 | -1.92 | 0 | miRanda | -0.31 | 0 | NA | |
47 | hsa-miR-342-3p | ANGPTL4 | 1.22 | 0 | -2.45 | 0 | miRanda | -0.52 | 0 | NA | |
48 | hsa-miR-342-3p | ANK2 | 1.22 | 0 | -2.51 | 0 | miRanda; miRNATAP | -0.28 | 0 | NA | |
49 | hsa-miR-342-3p | ANKDD1A | 1.22 | 0 | -1.5 | 0 | miRanda | -0.15 | 0 | NA | |
50 | hsa-miR-214-3p | ANKRD23 | -0.52 | 0.00021 | 0.4 | 7.0E-5 | mirMAP | -0.1 | 3.0E-5 | NA | |
51 | hsa-miR-214-3p | ANKRD52 | -0.52 | 0.00021 | 0.23 | 0.00024 | miRNATAP | -0.11 | 0 | NA | |
52 | hsa-miR-214-3p | ANKS1B | -0.52 | 0.00021 | 0.2 | 0.2194 | miRNATAP | -0.21 | 0 | NA | |
53 | hsa-miR-342-3p | ANTXR1 | 1.22 | 0 | -0.18 | 0.16983 | miRanda | -0.13 | 2.0E-5 | NA | |
54 | hsa-miR-342-3p | ANXA8 | 1.22 | 0 | -2.01 | 0 | MirTarget; miRanda | -0.61 | 0 | NA | |
55 | hsa-miR-342-3p | APOLD1 | 1.22 | 0 | -1.8 | 0 | MirTarget; miRanda | -0.17 | 0 | NA | |
56 | hsa-miR-342-3p | AQP4 | 1.22 | 0 | -2.95 | 0 | miRanda | -0.35 | 0 | NA | |
57 | hsa-miR-342-3p | ARAP3 | 1.22 | 0 | -1.27 | 0 | mirMAP | -0.23 | 0 | NA | |
58 | hsa-miR-532-3p | ARFIP2 | -0.4 | 0.00687 | 0.83 | 0 | PITA | -0.2 | 0 | NA | |
59 | hsa-miR-342-3p | ARHGAP21 | 1.22 | 0 | -1.05 | 0 | miRanda | -0.19 | 0 | NA | |
60 | hsa-miR-342-3p | ARHGAP26 | 1.22 | 0 | -1.51 | 0 | mirMAP | -0.16 | 0 | NA | |
61 | hsa-miR-532-3p | ARHGAP6 | -0.4 | 0.00687 | -1.65 | 0 | PITA | -0.16 | 0 | NA | |
62 | hsa-miR-342-3p | ARHGEF9 | 1.22 | 0 | -0.44 | 0 | miRanda | -0.1 | 0 | NA | |
63 | hsa-miR-342-3p | ARID5B | 1.22 | 0 | -1.75 | 0 | PITA; miRanda | -0.16 | 0 | NA | |
64 | hsa-miR-342-3p | ARL10 | 1.22 | 0 | -1.27 | 0 | mirMAP | -0.25 | 0 | NA | |
65 | hsa-miR-532-3p | ARL3 | -0.4 | 0.00687 | 0.59 | 0 | PITA | -0.13 | 0 | NA | |
66 | hsa-miR-342-3p | ASB1 | 1.22 | 0 | -0.93 | 0 | mirMAP | -0.12 | 0 | NA | |
67 | hsa-miR-214-3p | ASF1B | -0.52 | 0.00021 | 3.18 | 0 | miRNAWalker2 validate | -0.24 | 0 | NA | |
68 | hsa-miR-342-3p | ASTN1 | 1.22 | 0 | -2.96 | 0 | miRanda | -0.35 | 0 | NA | |
69 | hsa-miR-342-3p | ATF3 | 1.22 | 0 | -2.25 | 0 | miRanda | -0.28 | 0 | NA | |
70 | hsa-miR-342-3p | ATP10B | 1.22 | 0 | -1.05 | 8.0E-5 | miRanda | -0.46 | 0 | NA | |
71 | hsa-miR-342-3p | ATP11A | 1.22 | 0 | -0.67 | 0 | miRanda | -0.21 | 0 | NA | |
72 | hsa-miR-532-3p | ATP1A2 | -0.4 | 0.00687 | -5.48 | 0 | MirTarget | -0.51 | 0 | NA | |
73 | hsa-miR-214-3p | ATP2A3 | -0.52 | 0.00021 | 1.22 | 0 | MirTarget | -0.14 | 0.00049 | NA | |
74 | hsa-miR-342-3p | ATP2B4 | 1.22 | 0 | -1.11 | 0 | mirMAP | -0.13 | 0 | NA | |
75 | hsa-miR-574-3p | ATPIF1 | -0.8 | 0 | 1.07 | 0 | PITA | -0.23 | 0 | NA | |
76 | hsa-miR-342-3p | ATXN1L | 1.22 | 0 | -0.97 | 0 | miRNATAP | -0.14 | 0 | NA | |
77 | hsa-miR-143-5p | B3GAT3 | -1.09 | 0 | 1.08 | 0 | miRNATAP | -0.16 | 0 | NA | |
78 | hsa-miR-342-3p | B3GNT3 | 1.22 | 0 | -1.39 | 0 | miRanda | -0.55 | 0 | NA | |
79 | hsa-miR-342-3p | B3GNT7 | 1.22 | 0 | 0.2 | 0.16025 | MirTarget; miRanda | -0.23 | 0 | NA | |
80 | hsa-miR-342-3p | B4GALT5 | 1.22 | 0 | -0.34 | 4.0E-5 | mirMAP | -0.11 | 0 | NA | |
81 | hsa-miR-342-3p | BAG2 | 1.22 | 0 | -0.04 | 0.72195 | miRanda | -0.2 | 0 | NA | |
82 | hsa-miR-214-5p | BATF2 | 0.05 | 0.67611 | 0.32 | 0.07164 | MirTarget | -0.18 | 0.00043 | NA | |
83 | hsa-miR-214-3p | BAZ2A | -0.52 | 0.00021 | -0.1 | 0.10091 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
84 | hsa-miR-532-3p | BBC3 | -0.4 | 0.00687 | 1.65 | 0 | PITA; miRNATAP | -0.35 | 0 | NA | |
85 | hsa-miR-342-3p | BBOX1 | 1.22 | 0 | -3.62 | 0 | miRanda | -0.84 | 0 | NA | |
86 | hsa-miR-342-3p | BCL11A | 1.22 | 0 | -1.42 | 0 | miRanda | -0.55 | 0 | NA | |
87 | hsa-miR-193a-5p | BCL11B | -1.15 | 0 | -0.26 | 0.19747 | PITA; TargetScan; miRNATAP | -0.18 | 0.01362 | NA | |
88 | hsa-miR-24-2-5p | BCL2 | -0.22 | 0.05957 | -0.9 | 0 | miRNAWalker2 validate; miRTarBase | -0.31 | 0 | NA | |
89 | hsa-miR-193a-5p | BCL7C | -1.15 | 0 | 0.83 | 0 | PITA; TargetScan | -0.23 | 0 | NA | |
90 | hsa-miR-210-3p | BDNF | 2.38 | 0 | -1.6 | 0 | miRNAWalker2 validate; miRTarBase | -0.12 | 7.0E-5 | NA | |
91 | hsa-miR-342-3p | BHLHE41 | 1.22 | 0 | -1.53 | 0 | miRanda | -0.2 | 0 | NA | |
92 | hsa-miR-193a-5p | BMF | -1.15 | 0 | 0.83 | 0 | TargetScan; miRNATAP | -0.18 | 0 | NA | |
93 | hsa-miR-342-3p | BMP7 | 1.22 | 0 | -0.57 | 0.0198 | miRNAWalker2 validate; miRTarBase; miRanda | -0.4 | 0 | NA | |
94 | hsa-miR-342-3p | BNC1 | 1.22 | 0 | -2.84 | 0 | miRanda | -0.45 | 0 | NA | |
95 | hsa-miR-214-3p | BRSK2 | -0.52 | 0.00021 | 1.86 | 0 | mirMAP | -0.22 | 0.00189 | NA | |
96 | hsa-miR-214-3p | BSN | -0.52 | 0.00021 | -0.24 | 0.13233 | mirMAP | -0.15 | 0.00013 | NA | |
97 | hsa-miR-143-5p | BSPRY | -1.09 | 0 | 1.6 | 0 | MirTarget | -0.17 | 0 | NA | |
98 | hsa-miR-342-3p | BTG3 | 1.22 | 0 | -0.4 | 0.00167 | miRanda | -0.25 | 0 | NA | |
99 | hsa-miR-342-3p | C10orf10 | 1.22 | 0 | -2.19 | 0 | mirMAP | -0.38 | 0 | NA | |
100 | hsa-miR-532-3p | C16orf58 | -0.4 | 0.00687 | 0.72 | 0 | miRNATAP | -0.12 | 0 | NA | |
101 | hsa-miR-214-3p | C16orf59 | -0.52 | 0.00021 | 3.18 | 0 | mirMAP | -0.22 | 0 | NA | |
102 | hsa-miR-342-3p | C17orf51 | 1.22 | 0 | -1.38 | 0 | mirMAP | -0.37 | 0 | NA | |
103 | hsa-miR-342-3p | C1orf115 | 1.22 | 0 | -1.55 | 0 | mirMAP | -0.15 | 8.0E-5 | NA | |
104 | hsa-miR-342-3p | C1orf198 | 1.22 | 0 | -0.18 | 0.02916 | mirMAP | -0.15 | 0 | NA | |
105 | hsa-miR-532-3p | C3orf18 | -0.4 | 0.00687 | -0.47 | 7.0E-5 | miRNATAP | -0.27 | 0 | NA | |
106 | hsa-miR-342-3p | C3orf70 | 1.22 | 0 | -0.82 | 0 | mirMAP | -0.15 | 1.0E-5 | NA | |
107 | hsa-miR-342-3p | C6orf223 | 1.22 | 0 | 1.13 | 0.00032 | mirMAP | -0.28 | 0.00023 | NA | |
108 | hsa-miR-342-3p | CACNA1C | 1.22 | 0 | -0.83 | 0 | MirTarget; PITA; miRanda; miRNATAP | -0.12 | 0.00028 | NA | |
109 | hsa-miR-532-3p | CACNA1I | -0.4 | 0.00687 | 0.62 | 0.00607 | mirMAP | -0.12 | 0.01951 | NA | |
110 | hsa-miR-342-3p | CADM3 | 1.22 | 0 | -3.48 | 0 | miRanda | -0.35 | 0 | NA | |
111 | hsa-miR-532-3p | CADM3 | -0.4 | 0.00687 | -3.48 | 0 | MirTarget | -0.29 | 4.0E-5 | NA | |
112 | hsa-miR-342-3p | CAMK2D | 1.22 | 0 | -0.88 | 0 | miRanda | -0.13 | 0 | NA | |
113 | hsa-miR-214-3p | CAPRIN1 | -0.52 | 0.00021 | 0.34 | 0 | MirTarget | -0.11 | 0 | NA | |
114 | hsa-miR-214-3p | CARTPT | -0.52 | 0.00021 | 0.49 | 0.2615 | MirTarget | -0.41 | 0.00011 | NA | |
115 | hsa-miR-214-3p | CASKIN1 | -0.52 | 0.00021 | 2.05 | 0 | miRNATAP | -0.25 | 0 | NA | |
116 | hsa-miR-342-3p | CAV1 | 1.22 | 0 | -3.35 | 0 | miRanda | -0.37 | 0 | NA | |
117 | hsa-miR-342-3p | CBX2 | 1.22 | 0 | 1.77 | 0 | mirMAP | -0.17 | 0.00048 | NA | |
118 | hsa-miR-342-3p | CCDC141 | 1.22 | 0 | -2.66 | 0 | miRanda | -0.21 | 0 | NA | |
119 | hsa-miR-342-3p | CCDC68 | 1.22 | 0 | -2.06 | 0 | miRanda | -0.11 | 0.04166 | NA | |
120 | hsa-miR-532-3p | CCDC68 | -0.4 | 0.00687 | -2.06 | 0 | MirTarget | -0.25 | 0 | NA | |
121 | hsa-miR-342-3p | CCL8 | 1.22 | 0 | -1.17 | 0 | miRanda | -0.17 | 0.00081 | NA | |
122 | hsa-miR-214-5p | CCND1 | 0.05 | 0.67611 | 0.79 | 0 | MirTarget | -0.11 | 0.01381 | NA | |
123 | hsa-miR-342-3p | CCND2 | 1.22 | 0 | -1.32 | 0 | miRNAWalker2 validate; mirMAP | -0.1 | 0.00019 | NA | |
124 | hsa-miR-193a-5p | CCNL2 | -1.15 | 0 | -0.08 | 0.37557 | PITA | -0.1 | 0.00085 | NA | |
125 | hsa-miR-193a-5p | CCT3 | -1.15 | 0 | 1.21 | 0 | miRNATAP | -0.12 | 1.0E-5 | NA | |
126 | hsa-miR-342-3p | CD109 | 1.22 | 0 | -0.52 | 0.00083 | mirMAP | -0.18 | 0 | NA | |
127 | hsa-miR-193a-5p | CD247 | -1.15 | 0 | -0.08 | 0.66708 | miRNATAP | -0.17 | 0.01089 | NA | |
128 | hsa-miR-342-3p | CD302 | 1.22 | 0 | -1.77 | 0 | miRanda | -0.12 | 4.0E-5 | NA | |
129 | hsa-miR-342-3p | CD55 | 1.22 | 0 | -0.36 | 0.00102 | miRanda | -0.18 | 0 | NA | |
130 | hsa-miR-342-3p | CDH13 | 1.22 | 0 | -1.59 | 0 | miRanda | -0.19 | 0 | NA | |
131 | hsa-miR-342-3p | CDH23 | 1.22 | 0 | -2.27 | 0 | PITA | -0.35 | 0 | NA | |
132 | hsa-miR-532-3p | CDH23 | -0.4 | 0.00687 | -2.27 | 0 | mirMAP | -0.19 | 0 | NA | |
133 | hsa-miR-342-3p | CDH8 | 1.22 | 0 | -1.56 | 0 | miRanda | -0.18 | 0.00034 | NA | |
134 | hsa-miR-214-3p | CECR6 | -0.52 | 0.00021 | 0.08 | 0.58303 | mirMAP | -0.1 | 0.00358 | NA | |
135 | hsa-miR-342-3p | CELF2 | 1.22 | 0 | -2.12 | 0 | miRanda | -0.22 | 0 | NA | |
136 | hsa-miR-342-3p | CELF4 | 1.22 | 0 | -0.14 | 0.49289 | miRanda | -0.13 | 0.00668 | NA | |
137 | hsa-miR-193a-5p | CELF5 | -1.15 | 0 | -0.96 | 0.00036 | miRNATAP | -0.3 | 0.00195 | NA | |
138 | hsa-miR-214-3p | CELSR1 | -0.52 | 0.00021 | 1.62 | 0 | mirMAP | -0.19 | 1.0E-5 | NA | |
139 | hsa-miR-214-3p | CELSR2 | -0.52 | 0.00021 | 0.81 | 0 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
140 | hsa-miR-193a-5p | CELSR3 | -1.15 | 0 | 2.04 | 0 | PITA | -0.16 | 0.01897 | NA | |
141 | hsa-miR-214-3p | CENPO | -0.52 | 0.00021 | 1.2 | 0 | miRNATAP | -0.13 | 0 | NA | |
142 | hsa-miR-193a-5p | CENPP | -1.15 | 0 | 1.39 | 0 | mirMAP | -0.37 | 0 | NA | |
143 | hsa-miR-342-3p | CENPV | 1.22 | 0 | -0.6 | 0.00178 | miRanda | -0.19 | 4.0E-5 | NA | |
144 | hsa-miR-342-3p | CFL2 | 1.22 | 0 | -1.91 | 0 | PITA; miRanda | -0.18 | 0 | NA | |
145 | hsa-miR-532-3p | CGNL1 | -0.4 | 0.00687 | -0.82 | 0 | MirTarget | -0.16 | 0 | NA | |
146 | hsa-miR-342-3p | CGREF1 | 1.22 | 0 | 0.6 | 0.00031 | miRanda | -0.14 | 0.00068 | NA | |
147 | hsa-miR-342-3p | CHD5 | 1.22 | 0 | -0.23 | 0.28718 | mirMAP | -0.11 | 0.04072 | NA | |
148 | hsa-miR-193a-5p | CHERP | -1.15 | 0 | 0.51 | 0 | TargetScan | -0.13 | 0 | NA | |
149 | hsa-miR-342-3p | CHL1 | 1.22 | 0 | -4.19 | 0 | miRanda | -0.42 | 0 | NA | |
150 | hsa-miR-342-3p | CHODL | 1.22 | 0 | -2.01 | 0 | miRanda | -0.53 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEUROGENESIS | 145 | 1402 | 7.478e-21 | 3.48e-17 |
2 | REGULATION OF CELL DIFFERENTIATION | 135 | 1492 | 1.286e-14 | 1.995e-11 |
3 | CELL DEVELOPMENT | 131 | 1426 | 1.076e-14 | 1.995e-11 |
4 | NEURON DIFFERENTIATION | 93 | 874 | 2.791e-14 | 3.247e-11 |
5 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 46 | 306 | 1.27e-12 | 1.182e-09 |
6 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 140 | 1672 | 1.566e-12 | 1.214e-09 |
7 | NEURON DEVELOPMENT | 75 | 687 | 2.96e-12 | 1.968e-09 |
8 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 62 | 513 | 3.424e-12 | 1.992e-09 |
9 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 114 | 1275 | 4.284e-12 | 2.215e-09 |
10 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 84 | 823 | 5.06e-12 | 2.354e-09 |
11 | REGULATION OF NEURON DIFFERENTIATION | 63 | 554 | 3.184e-11 | 1.329e-08 |
12 | CELLULAR COMPONENT MORPHOGENESIS | 87 | 900 | 3.714e-11 | 1.329e-08 |
13 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 37 | 232 | 3.563e-11 | 1.329e-08 |
14 | NEURON PROJECTION MORPHOGENESIS | 51 | 402 | 5.143e-11 | 1.709e-08 |
15 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 48 | 368 | 7.287e-11 | 2.261e-08 |
16 | LOCOMOTION | 100 | 1114 | 8.265e-11 | 2.404e-08 |
17 | POSITIVE REGULATION OF CELL COMMUNICATION | 125 | 1532 | 1.619e-10 | 4.432e-08 |
18 | POSITIVE REGULATION OF CELL DEVELOPMENT | 55 | 472 | 2.369e-10 | 6.123e-08 |
19 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 88 | 957 | 3.741e-10 | 7.568e-08 |
20 | NEURON PROJECTION DEVELOPMENT | 60 | 545 | 3.48e-10 | 7.568e-08 |
21 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 100 | 1142 | 3.28e-10 | 7.568e-08 |
22 | BEHAVIOR | 58 | 516 | 3.106e-10 | 7.568e-08 |
23 | TISSUE DEVELOPMENT | 123 | 1518 | 3.591e-10 | 7.568e-08 |
24 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 115 | 1395 | 5.293e-10 | 1.026e-07 |
25 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 138 | 1784 | 5.987e-10 | 1.114e-07 |
26 | REGULATION OF GROWTH | 65 | 633 | 1.144e-09 | 2.048e-07 |
27 | ORGAN MORPHOGENESIS | 79 | 841 | 1.194e-09 | 2.058e-07 |
28 | BLOOD VESSEL MORPHOGENESIS | 45 | 364 | 1.636e-09 | 2.719e-07 |
29 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 40 | 303 | 1.984e-09 | 3.183e-07 |
30 | REGULATION OF CELL DEVELOPMENT | 78 | 836 | 2.08e-09 | 3.226e-07 |
31 | REGULATION OF CELL PROLIFERATION | 119 | 1496 | 2.182e-09 | 3.275e-07 |
32 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 50 | 437 | 2.935e-09 | 4.267e-07 |
33 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 80 | 876 | 3.409e-09 | 4.806e-07 |
34 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 74 | 788 | 4.17e-09 | 5.544e-07 |
35 | CIRCULATORY SYSTEM DEVELOPMENT | 74 | 788 | 4.17e-09 | 5.544e-07 |
36 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 71 | 750 | 6.26e-09 | 8.091e-07 |
37 | REGULATION OF MEMBRANE POTENTIAL | 42 | 343 | 7.625e-09 | 9.589e-07 |
38 | SKELETAL SYSTEM DEVELOPMENT | 50 | 455 | 1.126e-08 | 1.378e-06 |
39 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 125 | 1656 | 1.874e-08 | 2.236e-06 |
40 | NEURON PROJECTION GUIDANCE | 30 | 205 | 1.977e-08 | 2.299e-06 |
41 | SENSORY ORGAN DEVELOPMENT | 52 | 493 | 2.269e-08 | 2.575e-06 |
42 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 140 | 1929 | 2.714e-08 | 2.937e-06 |
43 | CELL PROJECTION ORGANIZATION | 79 | 902 | 2.697e-08 | 2.937e-06 |
44 | VASCULATURE DEVELOPMENT | 50 | 469 | 3.012e-08 | 3.185e-06 |
45 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 45 | 408 | 5.486e-08 | 5.673e-06 |
46 | BIOLOGICAL ADHESION | 86 | 1032 | 6.071e-08 | 6.141e-06 |
47 | ANGIOGENESIS | 36 | 293 | 8.212e-08 | 8.13e-06 |
48 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 69 | 771 | 9.417e-08 | 9.129e-06 |
49 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 25 | 162 | 1.04e-07 | 9.873e-06 |
50 | MUSCLE STRUCTURE DEVELOPMENT | 46 | 432 | 1.118e-07 | 1.04e-05 |
51 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 85 | 1036 | 1.434e-07 | 1.283e-05 |
52 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 85 | 1036 | 1.434e-07 | 1.283e-05 |
53 | CELL CELL SIGNALING | 68 | 767 | 1.666e-07 | 1.436e-05 |
54 | EMBRYONIC MORPHOGENESIS | 53 | 539 | 1.666e-07 | 1.436e-05 |
55 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 104 | 1360 | 1.818e-07 | 1.538e-05 |
56 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 24 | 156 | 1.976e-07 | 1.642e-05 |
57 | CELL PART MORPHOGENESIS | 59 | 633 | 2.122e-07 | 1.732e-05 |
58 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 128 | 1791 | 2.784e-07 | 2.233e-05 |
59 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 83 | 1021 | 2.987e-07 | 2.265e-05 |
60 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 82 | 1004 | 2.917e-07 | 2.265e-05 |
61 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 57 | 609 | 2.982e-07 | 2.265e-05 |
62 | NEGATIVE REGULATION OF NEURON DEATH | 25 | 171 | 3.018e-07 | 2.265e-05 |
63 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 118 | 1618 | 3.098e-07 | 2.288e-05 |
64 | EMBRYO DEVELOPMENT | 75 | 894 | 3.439e-07 | 2.5e-05 |
65 | POSITIVE REGULATION OF AXONOGENESIS | 15 | 69 | 4.304e-07 | 3.081e-05 |
66 | MODULATION OF SYNAPTIC TRANSMISSION | 35 | 301 | 4.736e-07 | 3.339e-05 |
67 | SINGLE ORGANISM BEHAVIOR | 41 | 384 | 5.083e-07 | 3.53e-05 |
68 | POSITIVE REGULATION OF GROWTH | 30 | 238 | 5.639e-07 | 3.858e-05 |
69 | SKELETAL SYSTEM MORPHOGENESIS | 27 | 201 | 5.836e-07 | 3.935e-05 |
70 | INTRACELLULAR SIGNAL TRANSDUCTION | 114 | 1572 | 6.682e-07 | 4.441e-05 |
71 | REGULATION OF ACTION POTENTIAL | 11 | 38 | 7.053e-07 | 4.622e-05 |
72 | EPITHELIUM DEVELOPMENT | 77 | 945 | 7.495e-07 | 4.777e-05 |
73 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 68 | 799 | 7.432e-07 | 4.777e-05 |
74 | REGULATION OF CELL GROWTH | 41 | 391 | 8.159e-07 | 4.999e-05 |
75 | TUBE DEVELOPMENT | 52 | 552 | 8.165e-07 | 4.999e-05 |
76 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 68 | 801 | 8.127e-07 | 4.999e-05 |
77 | REGULATION OF MAPK CASCADE | 59 | 660 | 8.528e-07 | 5.153e-05 |
78 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 89 | 1152 | 9.824e-07 | 5.86e-05 |
79 | REGULATION OF LIPASE ACTIVITY | 16 | 83 | 1.006e-06 | 5.926e-05 |
80 | POSITIVE REGULATION OF KINASE ACTIVITY | 47 | 482 | 1.059e-06 | 6.159e-05 |
81 | EAR DEVELOPMENT | 26 | 195 | 1.085e-06 | 6.234e-05 |
82 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 110 | 1518 | 1.114e-06 | 6.32e-05 |
83 | POSITIVE REGULATION OF CELL GROWTH | 22 | 148 | 1.15e-06 | 6.447e-05 |
84 | SKIN DEVELOPMENT | 27 | 211 | 1.529e-06 | 8.47e-05 |
85 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 87 | 1135 | 1.806e-06 | 9.887e-05 |
86 | REGULATION OF SYSTEM PROCESS | 48 | 507 | 1.88e-06 | 0.0001017 |
87 | REGULATION OF CARDIAC MUSCLE CELL CONTRACTION | 9 | 27 | 1.964e-06 | 0.0001051 |
88 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 12 | 50 | 2.012e-06 | 0.0001064 |
89 | REGULATION OF KINASE ACTIVITY | 65 | 776 | 2.252e-06 | 0.0001177 |
90 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 127 | 1848 | 2.442e-06 | 0.0001262 |
91 | NEGATIVE REGULATION OF GENE EXPRESSION | 107 | 1493 | 2.632e-06 | 0.0001346 |
92 | POSITIVE REGULATION OF CELL PROLIFERATION | 67 | 814 | 2.857e-06 | 0.0001445 |
93 | POSITIVE REGULATION OF MAPK CASCADE | 45 | 470 | 2.921e-06 | 0.0001446 |
94 | REGULATION OF PROTEIN MODIFICATION PROCESS | 119 | 1710 | 2.903e-06 | 0.0001446 |
95 | APPENDAGE DEVELOPMENT | 23 | 169 | 3.14e-06 | 0.0001522 |
96 | LIMB DEVELOPMENT | 23 | 169 | 3.14e-06 | 0.0001522 |
97 | REGULATION OF TRANSPORT | 124 | 1804 | 3.237e-06 | 0.0001553 |
98 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 77 | 983 | 3.319e-06 | 0.0001576 |
99 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 62 | 740 | 3.842e-06 | 0.0001806 |
100 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 70 | 872 | 4.087e-06 | 0.0001883 |
101 | REGULATION OF CELL MORPHOGENESIS | 50 | 552 | 4.068e-06 | 0.0001883 |
102 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 106 | 1492 | 4.35e-06 | 0.0001985 |
103 | COGNITION | 29 | 251 | 5.075e-06 | 0.0002293 |
104 | REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 9 | 30 | 5.294e-06 | 0.0002368 |
105 | REGULATION OF NEURON DEATH | 29 | 252 | 5.489e-06 | 0.0002433 |
106 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 13 | 64 | 5.628e-06 | 0.0002471 |
107 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 35 | 337 | 6.363e-06 | 0.000274 |
108 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 99 | 1381 | 6.373e-06 | 0.000274 |
109 | REGULATION OF BLOOD CIRCULATION | 32 | 295 | 6.42e-06 | 0.000274 |
110 | NEGATIVE REGULATION OF CELL COMMUNICATION | 88 | 1192 | 7.042e-06 | 0.0002979 |
111 | REGULATION OF HEART RATE | 15 | 86 | 7.969e-06 | 0.0003341 |
112 | RESPONSE TO EXTERNAL STIMULUS | 123 | 1821 | 8.294e-06 | 0.0003446 |
113 | CHEMICAL HOMEOSTASIS | 69 | 874 | 8.404e-06 | 0.0003461 |
114 | UROGENITAL SYSTEM DEVELOPMENT | 32 | 299 | 8.49e-06 | 0.0003465 |
115 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 122 | 1805 | 8.791e-06 | 0.0003557 |
116 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 106 | 1517 | 9.008e-06 | 0.0003582 |
117 | POSITIVE REGULATION OF GENE EXPRESSION | 118 | 1733 | 8.968e-06 | 0.0003582 |
118 | REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 9 | 32 | 9.551e-06 | 0.0003766 |
119 | REGULATION OF HYDROLASE ACTIVITY | 95 | 1327 | 1.05e-05 | 0.0004105 |
120 | SYNAPSE ORGANIZATION | 20 | 145 | 1.108e-05 | 0.000426 |
121 | REGULATION OF DEVELOPMENTAL GROWTH | 31 | 289 | 1.117e-05 | 0.000426 |
122 | REGULATION OF HEART CONTRACTION | 26 | 221 | 1.116e-05 | 0.000426 |
123 | REGULATION OF CELL PROJECTION ORGANIZATION | 49 | 558 | 1.174e-05 | 0.000444 |
124 | CELL MOTILITY | 66 | 835 | 1.275e-05 | 0.0004745 |
125 | LOCALIZATION OF CELL | 66 | 835 | 1.275e-05 | 0.0004745 |
126 | REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 19 | 1.319e-05 | 0.0004873 |
127 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 19 | 135 | 1.362e-05 | 0.0004953 |
128 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 29 | 264 | 1.353e-05 | 0.0004953 |
129 | REGULATION OF TRANSPORTER ACTIVITY | 24 | 198 | 1.457e-05 | 0.0005254 |
130 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 43 | 470 | 1.496e-05 | 0.0005356 |
131 | TISSUE MORPHOGENESIS | 47 | 533 | 1.586e-05 | 0.0005633 |
132 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 43 | 472 | 1.659e-05 | 0.0005804 |
133 | EPIDERMIS DEVELOPMENT | 28 | 253 | 1.651e-05 | 0.0005804 |
134 | CELLULAR RESPONSE TO ACID CHEMICAL | 22 | 175 | 1.846e-05 | 0.000637 |
135 | SKIN EPIDERMIS DEVELOPMENT | 13 | 71 | 1.848e-05 | 0.000637 |
136 | REGULATION OF ION HOMEOSTASIS | 24 | 201 | 1.875e-05 | 0.0006417 |
137 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 52 | 616 | 1.897e-05 | 0.0006444 |
138 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 14 | 2.036e-05 | 0.0006866 |
139 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 12 | 62 | 2.153e-05 | 0.0007208 |
140 | TAXIS | 42 | 464 | 2.415e-05 | 0.0008026 |
141 | PALLIUM DEVELOPMENT | 20 | 153 | 2.472e-05 | 0.0008157 |
142 | CELL JUNCTION ASSEMBLY | 18 | 129 | 2.566e-05 | 0.0008408 |
143 | REGULATION OF NEURON APOPTOTIC PROCESS | 23 | 192 | 2.638e-05 | 0.0008581 |
144 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 75 | 1008 | 2.656e-05 | 0.0008581 |
145 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 56 | 689 | 2.689e-05 | 0.0008628 |
146 | REGULATION OF GTPASE ACTIVITY | 55 | 673 | 2.725e-05 | 0.0008685 |
147 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 30 | 289 | 2.889e-05 | 0.0009144 |
148 | REGULATION OF MAP KINASE ACTIVITY | 32 | 319 | 3.134e-05 | 0.0009852 |
149 | BONE DEVELOPMENT | 20 | 156 | 3.285e-05 | 0.001026 |
150 | MUSCLE ORGAN DEVELOPMENT | 29 | 277 | 3.337e-05 | 0.001035 |
151 | NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 9 | 37 | 3.444e-05 | 0.001061 |
152 | GROWTH | 38 | 410 | 3.494e-05 | 0.00107 |
153 | CARDIAC MUSCLE CELL CONTRACTION | 8 | 29 | 3.52e-05 | 0.00107 |
154 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 10 | 46 | 3.637e-05 | 0.001099 |
155 | CIRCULATORY SYSTEM PROCESS | 35 | 366 | 3.715e-05 | 0.001115 |
156 | EMBRYONIC ORGAN MORPHOGENESIS | 29 | 279 | 3.809e-05 | 0.001129 |
157 | MUSCLE CELL DIFFERENTIATION | 26 | 237 | 3.802e-05 | 0.001129 |
158 | TUBE MORPHOGENESIS | 32 | 323 | 4e-05 | 0.001178 |
159 | REGULATION OF MUSCLE CONTRACTION | 19 | 147 | 4.581e-05 | 0.00134 |
160 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 68 | 905 | 4.702e-05 | 0.001359 |
161 | REGULATION OF INTRACELLULAR TRANSPORT | 51 | 621 | 4.682e-05 | 0.001359 |
162 | CELL GROWTH | 18 | 135 | 4.758e-05 | 0.001367 |
163 | MULTICELLULAR ORGANISMAL SIGNALING | 17 | 123 | 4.83e-05 | 0.001379 |
164 | NEGATIVE REGULATION OF CELL DEATH | 66 | 872 | 4.885e-05 | 0.001386 |
165 | REGULATION OF CELL DEATH | 100 | 1472 | 5.046e-05 | 0.001423 |
166 | TELENCEPHALON DEVELOPMENT | 25 | 228 | 5.367e-05 | 0.001504 |
167 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 9 | 39 | 5.401e-05 | 0.001505 |
168 | REGULATION OF CELLULAR LOCALIZATION | 89 | 1277 | 5.438e-05 | 0.001506 |
169 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 22 | 188 | 5.606e-05 | 0.001543 |
170 | MULTICELLULAR ORGANISMAL WATER HOMEOSTASIS | 11 | 58 | 5.749e-05 | 0.001573 |
171 | NEGATIVE REGULATION OF CELL PROLIFERATION | 52 | 643 | 5.904e-05 | 0.001607 |
172 | SYNAPSE ASSEMBLY | 12 | 69 | 6.538e-05 | 0.001769 |
173 | SYNAPTIC SIGNALING | 38 | 424 | 7.182e-05 | 0.001932 |
174 | RESPONSE TO ENDOGENOUS STIMULUS | 98 | 1450 | 7.319e-05 | 0.001957 |
175 | REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 11 | 7.463e-05 | 0.001984 |
176 | REGULATION OF SECRETION | 55 | 699 | 7.59e-05 | 0.002007 |
177 | PROTEIN AUTOPHOSPHORYLATION | 22 | 192 | 7.698e-05 | 0.002024 |
178 | GLAND DEVELOPMENT | 36 | 395 | 7.857e-05 | 0.002054 |
179 | REGULATION OF SMOOTH MUSCLE CONTRACTION | 11 | 60 | 7.956e-05 | 0.002068 |
180 | RESPONSE TO LIPID | 66 | 888 | 8.386e-05 | 0.002168 |
181 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 23 | 207 | 8.597e-05 | 0.00221 |
182 | CARDIAC CONDUCTION | 13 | 82 | 8.897e-05 | 0.002275 |
183 | REGULATION OF NEUROTRANSMITTER SECRETION | 10 | 51 | 9.256e-05 | 0.002353 |
184 | REGULATION OF AXONOGENESIS | 20 | 168 | 9.46e-05 | 0.002392 |
185 | PROTEIN PHOSPHORYLATION | 69 | 944 | 9.607e-05 | 0.002416 |
186 | REGULATION OF MUSCLE SYSTEM PROCESS | 22 | 195 | 9.698e-05 | 0.002426 |
187 | HAIR CYCLE | 13 | 83 | 0.0001011 | 0.002503 |
188 | MOLTING CYCLE | 13 | 83 | 0.0001011 | 0.002503 |
189 | REGULATION OF TRANSFERASE ACTIVITY | 69 | 946 | 0.0001023 | 0.00252 |
190 | REGULATION OF ION TRANSPORT | 48 | 592 | 0.0001058 | 0.002592 |
191 | RESPONSE TO MECHANICAL STIMULUS | 23 | 210 | 0.0001071 | 0.002608 |
192 | EYE DEVELOPMENT | 31 | 326 | 0.0001124 | 0.002723 |
193 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 30 | 312 | 0.0001182 | 0.00285 |
194 | POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 12 | 0.0001231 | 0.002952 |
195 | REGULATION OF CARTILAGE DEVELOPMENT | 11 | 63 | 0.0001261 | 0.003008 |
196 | CELL JUNCTION ORGANIZATION | 21 | 185 | 0.000127 | 0.003014 |
197 | CELL FATE COMMITMENT | 24 | 227 | 0.0001328 | 0.003137 |
198 | EMBRYONIC ORGAN DEVELOPMENT | 36 | 406 | 0.0001364 | 0.003206 |
199 | NEUROMUSCULAR PROCESS | 14 | 97 | 0.0001373 | 0.00321 |
200 | REGULATION OF NEUROTRANSMITTER TRANSPORT | 11 | 64 | 0.000146 | 0.003396 |
201 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 16 | 122 | 0.00015 | 0.003456 |
202 | REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 16 | 122 | 0.00015 | 0.003456 |
203 | POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 19 | 0.0001509 | 0.003459 |
204 | NEURON MIGRATION | 15 | 110 | 0.0001541 | 0.003515 |
205 | ADULT BEHAVIOR | 17 | 135 | 0.0001563 | 0.003549 |
206 | REGULATION OF TRANSMEMBRANE TRANSPORT | 37 | 426 | 0.0001681 | 0.003796 |
207 | CELL PROLIFERATION | 52 | 672 | 0.000179 | 0.004023 |
208 | REGULATION OF NEUROTRANSMITTER LEVELS | 21 | 190 | 0.0001849 | 0.004136 |
209 | NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 5 | 13 | 0.0001924 | 0.00427 |
210 | DEVELOPMENTAL CELL GROWTH | 12 | 77 | 0.0001946 | 0.00427 |
211 | POSITIVE REGULATION OF LIPASE ACTIVITY | 11 | 66 | 0.0001939 | 0.00427 |
212 | REGULATION OF CARDIAC MUSCLE CONTRACTION | 11 | 66 | 0.0001939 | 0.00427 |
213 | CELL CELL ADHESION | 48 | 608 | 0.0001983 | 0.004332 |
214 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 17 | 138 | 0.0002046 | 0.004448 |
215 | REGULATION OF EXTENT OF CELL GROWTH | 14 | 101 | 0.0002124 | 0.004576 |
216 | PROTEIN O LINKED GLYCOSYLATION | 14 | 101 | 0.0002124 | 0.004576 |
217 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 37 | 0.0002284 | 0.004863 |
218 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 27 | 279 | 0.0002289 | 0.004863 |
219 | CAMP MEDIATED SIGNALING | 8 | 37 | 0.0002284 | 0.004863 |
220 | ACTIN FILAMENT BASED PROCESS | 38 | 450 | 0.0002435 | 0.005127 |
221 | REGULATION OF CHEMOTAXIS | 20 | 180 | 0.0002429 | 0.005127 |
222 | CONNECTIVE TISSUE DEVELOPMENT | 21 | 194 | 0.0002469 | 0.005161 |
223 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 22 | 208 | 0.0002473 | 0.005161 |
224 | REGULATION OF STRIATED MUSCLE CONTRACTION | 12 | 79 | 0.0002492 | 0.005177 |
225 | NERVE DEVELOPMENT | 11 | 68 | 0.0002546 | 0.005265 |
226 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 18 | 154 | 0.0002617 | 0.005342 |
227 | LOCOMOTORY BEHAVIOR | 20 | 181 | 0.0002616 | 0.005342 |
228 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 35 | 404 | 0.0002618 | 0.005342 |
229 | REGULATION OF THE FORCE OF HEART CONTRACTION | 7 | 29 | 0.0002731 | 0.005548 |
230 | REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 6 | 21 | 0.0002789 | 0.005642 |
231 | RESPONSE TO KETONE | 20 | 182 | 0.0002814 | 0.005667 |
232 | O GLYCAN PROCESSING | 10 | 58 | 0.0002826 | 0.005667 |
233 | VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 5 | 14 | 0.000288 | 0.005752 |
234 | SENSORY ORGAN MORPHOGENESIS | 24 | 239 | 0.0002899 | 0.005764 |
235 | INNER EAR MORPHOGENESIS | 13 | 92 | 0.0002917 | 0.005776 |
236 | RESPONSE TO NITROGEN COMPOUND | 62 | 859 | 0.0003026 | 0.005967 |
237 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 27 | 285 | 0.000322 | 0.006295 |
238 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 41 | 505 | 0.0003211 | 0.006295 |
239 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 13 | 93 | 0.0003251 | 0.006328 |
240 | VASCULOGENESIS | 10 | 59 | 0.0003264 | 0.006328 |
241 | RESPONSE TO EXTRACELLULAR STIMULUS | 37 | 441 | 0.0003312 | 0.006369 |
242 | WATER HOMEOSTASIS | 11 | 70 | 0.0003305 | 0.006369 |
243 | LEARNING | 16 | 131 | 0.0003433 | 0.006519 |
244 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 7 | 30 | 0.0003422 | 0.006519 |
245 | CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 7 | 30 | 0.0003422 | 0.006519 |
246 | REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 9 | 49 | 0.0003467 | 0.006557 |
247 | FAT CELL DIFFERENTIATION | 14 | 106 | 0.0003541 | 0.00667 |
248 | RESPONSE TO ABIOTIC STIMULUS | 71 | 1024 | 0.0003626 | 0.006804 |
249 | DEVELOPMENTAL GROWTH | 30 | 333 | 0.000366 | 0.00684 |
250 | BONE CELL DEVELOPMENT | 6 | 22 | 0.0003687 | 0.006854 |
251 | CELL MATRIX ADHESION | 15 | 119 | 0.0003698 | 0.006854 |
252 | DICARBOXYLIC ACID TRANSPORT | 11 | 71 | 0.0003751 | 0.006927 |
253 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 28 | 303 | 0.0003775 | 0.006942 |
254 | RESPONSE TO RETINOIC ACID | 14 | 107 | 0.0003905 | 0.007153 |
255 | FORELIMB MORPHOGENESIS | 8 | 40 | 0.0004026 | 0.007317 |
256 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 26 | 274 | 0.0004019 | 0.007317 |
257 | REGULATION OF DENDRITE DEVELOPMENT | 15 | 120 | 0.000405 | 0.007332 |
258 | SECOND MESSENGER MEDIATED SIGNALING | 18 | 160 | 0.000419 | 0.007556 |
259 | MUSCLE TISSUE DEVELOPMENT | 26 | 275 | 0.000425 | 0.007606 |
260 | REGULATION OF SYNAPTIC VESICLE TRANSPORT | 7 | 31 | 0.0004246 | 0.007606 |
261 | REGULATION OF HOMEOSTATIC PROCESS | 37 | 447 | 0.0004288 | 0.007645 |
262 | MEMBRANE DEPOLARIZATION | 10 | 61 | 0.0004312 | 0.007658 |
263 | RESPONSE TO WOUNDING | 44 | 563 | 0.0004468 | 0.007905 |
264 | MORPHOGENESIS OF AN EPITHELIUM | 34 | 400 | 0.00045 | 0.007931 |
265 | INNERVATION | 6 | 23 | 0.0004795 | 0.008419 |
266 | HEART PROCESS | 12 | 85 | 0.0004977 | 0.008705 |
267 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 14 | 110 | 0.0005194 | 0.009052 |
268 | POSITIVE REGULATION OF LOCOMOTION | 35 | 420 | 0.0005366 | 0.009316 |
269 | FOREBRAIN DEVELOPMENT | 31 | 357 | 0.0005523 | 0.009554 |
270 | DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 5 | 16 | 0.0005819 | 0.009955 |
271 | MEGAKARYOCYTE DEVELOPMENT | 5 | 16 | 0.0005819 | 0.009955 |
272 | POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 5 | 16 | 0.0005819 | 0.009955 |
273 | NEGATIVE REGULATION OF PHOSPHORYLATION | 35 | 422 | 0.0005846 | 0.009964 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 66 | 629 | 3.448e-10 | 3.203e-07 |
2 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 41 | 315 | 1.907e-09 | 8.856e-07 |
3 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 41 | 328 | 6.314e-09 | 1.955e-06 |
4 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 96 | 1199 | 6.777e-08 | 1.574e-05 |
5 | REGULATORY REGION NUCLEIC ACID BINDING | 71 | 818 | 1.997e-07 | 3.71e-05 |
6 | SEQUENCE SPECIFIC DNA BINDING | 84 | 1037 | 2.932e-07 | 4.54e-05 |
7 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 29 | 226 | 5.969e-07 | 7.921e-05 |
8 | DOUBLE STRANDED DNA BINDING | 64 | 764 | 2.691e-06 | 0.0003125 |
9 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 15 | 81 | 3.692e-06 | 0.000343 |
10 | GROWTH FACTOR BINDING | 19 | 123 | 3.408e-06 | 0.000343 |
11 | GLYCOSAMINOGLYCAN BINDING | 25 | 205 | 8.742e-06 | 0.0007383 |
12 | KINASE BINDING | 52 | 606 | 1.213e-05 | 0.0009389 |
13 | PROTEIN DIMERIZATION ACTIVITY | 84 | 1149 | 1.649e-05 | 0.001178 |
14 | MOLECULAR FUNCTION REGULATOR | 95 | 1353 | 2.26e-05 | 0.001399 |
15 | RECEPTOR BINDING | 102 | 1476 | 2.128e-05 | 0.001399 |
16 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 12 | 64 | 3.008e-05 | 0.001747 |
17 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 35 | 371 | 4.909e-05 | 0.002551 |
18 | MACROMOLECULAR COMPLEX BINDING | 96 | 1399 | 4.943e-05 | 0.002551 |
19 | IDENTICAL PROTEIN BINDING | 85 | 1209 | 5.952e-05 | 0.00291 |
20 | ENZYME BINDING | 114 | 1737 | 6.303e-05 | 0.002928 |
21 | PROTEIN KINASE A BINDING | 9 | 42 | 0.0001004 | 0.004243 |
22 | PROTEIN KINASE ACTIVITY | 51 | 640 | 0.0001005 | 0.004243 |
23 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 24 | 228 | 0.0001421 | 0.00574 |
24 | CALCIUM ION BINDING | 53 | 697 | 0.0002392 | 0.009259 |
25 | CYTOSKELETAL PROTEIN BINDING | 60 | 819 | 0.0002567 | 0.009538 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 111 | 1151 | 6.354e-14 | 3.711e-11 |
2 | NEURON PART | 116 | 1265 | 5.078e-13 | 1.483e-10 |
3 | NEURON PROJECTION | 91 | 942 | 1.314e-11 | 2.558e-09 |
4 | CELL PROJECTION | 139 | 1786 | 3.397e-10 | 4.96e-08 |
5 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 129 | 1649 | 1.19e-09 | 1.39e-07 |
6 | SOMATODENDRITIC COMPARTMENT | 63 | 650 | 1.923e-08 | 1.871e-06 |
7 | MEMBRANE REGION | 92 | 1134 | 7.12e-08 | 5.94e-06 |
8 | SYNAPSE | 68 | 754 | 8.747e-08 | 6.385e-06 |
9 | DENDRITE | 47 | 451 | 1.549e-07 | 1.005e-05 |
10 | CELL CELL JUNCTION | 40 | 383 | 1.228e-06 | 7.173e-05 |
11 | PLASMA MEMBRANE REGION | 75 | 929 | 1.484e-06 | 7.879e-05 |
12 | AXON | 42 | 418 | 1.837e-06 | 8.941e-05 |
13 | CYTOPLASMIC REGION | 32 | 287 | 3.598e-06 | 0.0001611 |
14 | PRESYNAPTIC ACTIVE ZONE | 9 | 29 | 3.863e-06 | 0.0001611 |
15 | CELL BODY | 46 | 494 | 4.782e-06 | 0.0001862 |
16 | SYNAPSE PART | 53 | 610 | 7.034e-06 | 0.0002567 |
17 | PROTEINACEOUS EXTRACELLULAR MATRIX | 36 | 356 | 8.578e-06 | 0.0002947 |
18 | MEMBRANE MICRODOMAIN | 31 | 288 | 1.042e-05 | 0.000338 |
19 | EXTRACELLULAR MATRIX | 40 | 426 | 1.624e-05 | 0.0004992 |
20 | GOLGI APPARATUS PART | 68 | 893 | 3.109e-05 | 0.0008647 |
21 | T TUBULE | 10 | 45 | 2.968e-05 | 0.0008647 |
22 | CONTRACTILE FIBER | 24 | 211 | 4.174e-05 | 0.001108 |
23 | GOLGI MEMBRANE | 55 | 703 | 8.819e-05 | 0.002239 |
24 | ACTIN BASED CELL PROJECTION | 21 | 181 | 9.284e-05 | 0.002259 |
25 | CELL SURFACE | 58 | 757 | 0.0001006 | 0.002299 |
26 | CELL PROJECTION PART | 69 | 946 | 0.0001023 | 0.002299 |
27 | PRESYNAPSE | 28 | 283 | 0.0001215 | 0.002628 |
28 | I BAND | 16 | 121 | 0.000136 | 0.002837 |
29 | PLASMA MEMBRANE RAFT | 13 | 86 | 0.0001465 | 0.002951 |
30 | POSTSYNAPSE | 34 | 378 | 0.0001581 | 0.003077 |
31 | SARCOLEMMA | 16 | 125 | 0.0001997 | 0.003762 |
32 | RECEPTOR COMPLEX | 30 | 327 | 0.0002688 | 0.004905 |
33 | ANCHORING JUNCTION | 40 | 489 | 0.000325 | 0.005752 |
34 | SYNAPTIC MEMBRANE | 25 | 261 | 0.000448 | 0.007696 |
35 | INTERCALATED DISC | 9 | 51 | 0.0004728 | 0.00789 |
36 | AXON PART | 22 | 219 | 0.0005069 | 0.008224 |
37 | CELL PROJECTION CYTOPLASM | 9 | 52 | 0.0005488 | 0.008662 |
38 | CELL CORTEX | 23 | 238 | 0.0006587 | 0.009863 |
39 | EXTERNAL SIDE OF PLASMA MEMBRANE | 23 | 238 | 0.0006587 | 0.009863 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Calcium_signaling_pathway_hsa04020 | 21 | 182 | 0.0001005 | 0.005226 | |
2 | Rap1_signaling_pathway_hsa04015 | 22 | 206 | 0.0002156 | 0.005604 | |
3 | cAMP_signaling_pathway_hsa04024 | 21 | 198 | 0.0003264 | 0.005658 | |
4 | MAPK_signaling_pathway_hsa04010 | 27 | 295 | 0.0005526 | 0.007184 | |
5 | Hippo_signaling_pathway_hsa04390 | 17 | 154 | 0.0007438 | 0.007735 | |
6 | Focal_adhesion_hsa04510 | 19 | 199 | 0.002144 | 0.01858 | |
7 | Cell_adhesion_molecules_.CAMs._hsa04514 | 15 | 145 | 0.002823 | 0.02071 | |
8 | Jak_STAT_signaling_pathway_hsa04630 | 16 | 162 | 0.003318 | 0.02071 | |
9 | PI3K_Akt_signaling_pathway_hsa04151 | 28 | 352 | 0.003585 | 0.02071 | |
10 | Neuroactive_ligand_receptor_interaction_hsa04080 | 23 | 278 | 0.004916 | 0.02556 | |
11 | Gap_junction_hsa04540 | 10 | 88 | 0.007102 | 0.03243 | |
12 | Phospholipase_D_signaling_pathway_hsa04072 | 14 | 146 | 0.007484 | 0.03243 | |
13 | cGMP_PKG_signaling_pathway_hsa04022 | 15 | 163 | 0.008333 | 0.03333 | |
14 | Cytokine_cytokine_receptor_interaction_hsa04060 | 21 | 270 | 0.01351 | 0.0502 | |
15 | TGF_beta_signaling_pathway_hsa04350 | 9 | 84 | 0.01494 | 0.05181 | |
16 | Wnt_signaling_pathway_hsa04310 | 13 | 146 | 0.01731 | 0.05625 | |
17 | Ras_signaling_pathway_hsa04014 | 18 | 232 | 0.02156 | 0.06595 | |
18 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 11 | 139 | 0.05602 | 0.1572 | |
19 | Regulation_of_actin_cytoskeleton_hsa04810 | 15 | 208 | 0.05744 | 0.1572 | |
20 | ECM_receptor_interaction_hsa04512 | 7 | 82 | 0.08303 | 0.2159 | |
21 | ErbB_signaling_pathway_hsa04012 | 7 | 85 | 0.09614 | 0.2381 | |
22 | Adherens_junction_hsa04520 | 6 | 72 | 0.1133 | 0.2679 | |
23 | Endocytosis_hsa04144 | 15 | 244 | 0.1563 | 0.3432 | |
24 | mTOR_signaling_pathway_hsa04150 | 10 | 151 | 0.1584 | 0.3432 | |
25 | Apelin_signaling_pathway_hsa04371 | 9 | 137 | 0.1802 | 0.3748 | |
26 | Apoptosis_multiple_species_hsa04215 | 3 | 33 | 0.1926 | 0.3852 | |
27 | Oocyte_meiosis_hsa04114 | 8 | 124 | 0.2118 | 0.4079 | |
28 | AMPK_signaling_pathway_hsa04152 | 7 | 121 | 0.3225 | 0.5844 | |
29 | ABC_transporters_hsa02010 | 3 | 45 | 0.3427 | 0.5844 | |
30 | Mitophagy_animal_hsa04137 | 4 | 65 | 0.3504 | 0.5844 | |
31 | Hedgehog_signaling_pathway_hsa04340 | 3 | 47 | 0.3681 | 0.5844 | |
32 | TNF_signaling_pathway_hsa04668 | 6 | 108 | 0.3782 | 0.5844 | |
33 | Tight_junction_hsa04530 | 9 | 170 | 0.3816 | 0.5844 | |
34 | p53_signaling_pathway_hsa04115 | 4 | 68 | 0.3821 | 0.5844 | |
35 | Ferroptosis_hsa04216 | 2 | 40 | 0.555 | 0.8239 | |
36 | FoxO_signaling_pathway_hsa04068 | 6 | 132 | 0.5704 | 0.8239 | |
37 | Phosphatidylinositol_signaling_system_hsa04070 | 4 | 99 | 0.6734 | 0.9081 | |
38 | Cell_cycle_hsa04110 | 5 | 124 | 0.6801 | 0.9081 | |
39 | HIF_1_signaling_pathway_hsa04066 | 4 | 100 | 0.6811 | 0.9081 | |
40 | Peroxisome_hsa04146 | 3 | 83 | 0.7414 | 0.929 | |
41 | Cellular_senescence_hsa04218 | 6 | 160 | 0.7503 | 0.929 | |
42 | Sphingolipid_signaling_pathway_hsa04071 | 4 | 118 | 0.7975 | 0.9644 | |
43 | Autophagy_animal_hsa04140 | 4 | 128 | 0.8457 | 0.9913 | |
44 | Necroptosis_hsa04217 | 5 | 164 | 0.878 | 0.9913 | |
45 | Apoptosis_hsa04210 | 4 | 138 | 0.8839 | 0.9913 |